Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Clinical opportunities and challenges in targeting tumour dormancy.

Hensel JA, Flaig TW, Theodorescu D.

Nat Rev Clin Oncol. 2013 Jan;10(1):41-51. doi: 10.1038/nrclinonc.2012.207. Epub 2012 Nov 27. Review.

PMID:
23183631
2.

Tumor dormancy and cancer stem cells: two sides of the same coin?

Kleffel S, Schatton T.

Adv Exp Med Biol. 2013;734:145-79. doi: 10.1007/978-1-4614-1445-2_8.

PMID:
23143979
3.

Tumor dormancy: long-term survival in a hostile environment.

Quesnel B.

Adv Exp Med Biol. 2013;734:181-200. doi: 10.1007/978-1-4614-1445-2_9.

PMID:
23143980
4.

Cancer micrometastasis and tumour dormancy.

Wikman H, Vessella R, Pantel K.

APMIS. 2008 Jul-Aug;116(7-8):754-70. doi: 10.1111/j.1600-0463.2008.01033.x. Review.

PMID:
18834417
5.

Extracellular matrix: a gatekeeper in the transition from dormancy to metastatic growth.

Barkan D, Green JE, Chambers AF.

Eur J Cancer. 2010 May;46(7):1181-8. doi: 10.1016/j.ejca.2010.02.027. Epub 2010 Mar 19. Review.

6.

Microenvironments dictating tumor cell dormancy.

Bragado P, Sosa MS, Keely P, Condeelis J, Aguirre-Ghiso JA.

Recent Results Cancer Res. 2012;195:25-39. doi: 10.1007/978-3-642-28160-0_3. Review.

7.

Tumor dormancy: potential therapeutic target in tumor recurrence and metastasis prevention.

Wang SH, Lin SY.

Exp Hematol Oncol. 2013 Oct 16;2(1):29. doi: 10.1186/2162-3619-2-29.

8.

Models, mechanisms and clinical evidence for cancer dormancy.

Aguirre-Ghiso JA.

Nat Rev Cancer. 2007 Nov;7(11):834-46. Review.

9.

Mechanisms of disseminated cancer cell dormancy: an awakening field.

Sosa MS, Bragado P, Aguirre-Ghiso JA.

Nat Rev Cancer. 2014 Sep;14(9):611-22. doi: 10.1038/nrc3793. Epub 2014 Aug 14. Review.

10.

Cell dormancy and tumor refractory.

Yu Y, Zhu Z.

Anticancer Agents Med Chem. 2013 Feb;13(2):199-202. Review.

PMID:
22934702
11.

Molecular mechanisms underlying tumor dormancy.

Almog N.

Cancer Lett. 2010 Aug 28;294(2):139-46. doi: 10.1016/j.canlet.2010.03.004. Epub 2010 Apr 2. Review.

PMID:
20363069
12.

Genes and regulatory pathways involved in persistence of dormant micro-tumors.

Almog N.

Adv Exp Med Biol. 2013;734:3-17. doi: 10.1007/978-1-4614-1445-2_1.

PMID:
23143972
13.

Cancer dormancy: a model of early dissemination and late cancer recurrence.

Páez D, Labonte MJ, Bohanes P, Zhang W, Benhanim L, Ning Y, Wakatsuki T, Loupakis F, Lenz HJ.

Clin Cancer Res. 2012 Feb 1;18(3):645-53. doi: 10.1158/1078-0432.CCR-11-2186. Epub 2011 Dec 9. Review.

14.

Label retaining cells in cancer--the dormant root of evil?

Schillert A, Trumpp A, Sprick MR.

Cancer Lett. 2013 Nov 28;341(1):73-9. doi: 10.1016/j.canlet.2013.04.019. Epub 2013 Apr 23. Review.

PMID:
23624300
15.

Dormancy of metastatic melanoma.

Ossowski L, Aguirre-Ghiso JA.

Pigment Cell Melanoma Res. 2010 Feb;23(1):41-56. doi: 10.1111/j.1755-148X.2009.00647.x. Epub 2009 Oct 19. Review.

16.

Dormancy in solid tumors: implications for prostate cancer.

Ruppender NS, Morrissey C, Lange PH, Vessella RL.

Cancer Metastasis Rev. 2013 Dec;32(3-4):501-9. doi: 10.1007/s10555-013-9422-z. Review.

17.

Framework models of tumor dormancy from patient-derived observations.

Klein CA.

Curr Opin Genet Dev. 2011 Feb;21(1):42-9. doi: 10.1016/j.gde.2010.10.011. Epub 2010 Dec 8. Review.

PMID:
21145726
18.

Tumor dormancy of primary and secondary cancers.

Udagawa T.

APMIS. 2008 Jul-Aug;116(7-8):615-28. doi: 10.1111/j.1600-0463.2008.01077.x. Review.

PMID:
18834406
19.

Mechanisms of Metastatic Tumor Dormancy.

Osisami M, Keller ET.

J Clin Med. 2013 Sep 23;2(3):136-50. doi: 10.3390/jcm2030136. Review.

20.

Tumor dormancy and cancer stem cells: implications for the biology and treatment of breast cancer metastasis.

Allan AL, Vantyghem SA, Tuck AB, Chambers AF.

Breast Dis. 2006-2007;26:87-98. Review.

PMID:
17473368
Items per page

Supplemental Content

Write to the Help Desk